Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

Companies

Compass Pathways

Mentioned in 1 analyzed podcast episode across 1 show

Mentioned On

Episode Mentions

Motley Fool Money

Motley Fool Money · Apr 12, 2026

The Psychedelic Revolution

Publicly traded psychedelic biotech (CNPS) advancing phase 3 trials for COMP360 psilocybin treatment with recent 23% stock jump

Psychedelic-Assisted Therapy Clinical EfficacyTreatment-Resistant Depression Market OpportunityFDA Approval Pathways for Psychedelic Compounds
View Analysis